Year: 2024

WHO issues global health alert for Mpox virus as cases rise in Africa
17
Aug
Avatar photo
By Jean Thompson
Health

WHO issues global health alert for Mpox virus as cases rise in Africa

More news - Breaking news The World Health Organization (WHO) has stepped up its response to the mpox outbreak by declaring it a global health emergency. The declaration came on Wednesday, marking the second such declaration in the past three years as the virus rapidly spreads to multiple African nations. Currently, the Democratic Republic of the Congo is experiencing the most severe impact of the outbreak, with a reported count of 15,600 cases and 537 deaths. The current outbreak has surpassed the severity of the 2022 episode, during which a similar emergency was declared. Mpox, formerly known as monkeypox, was…
Read More
Cisco Systems Announces Significant Workforce Reduction, Plans to Cut 6,000 Jobs
17
Aug
Avatar photo
By Jean Thompson
Science and Technology

Cisco Systems Announces Significant Workforce Reduction, Plans to Cut 6,000 Jobs

More news - Breaking news Cisco Systems, a leading developer of computer networking solutions based in San Jose, California, said it will reduce its workforce by 7 percent, marking its second significant reduction this year. The decision means about 6,000 job losses from its 84,900-person workforce as of July 2023. Earlier this year, Cisco had already cut its workforce by 4,000. Despite the job cuts, Cisco reported net income of $2.16 billion for the latest quarter, a 45 percent decline from the previous year, with revenue falling 10 percent to $13.64 billion. However, those numbers still beat expectations set by…
Read More
Walmart Beats Financial Forecast, Improves Full-Year Projections on Steady Consumer Demand
16
Aug
Avatar photo
By Jean Thompson
Investments and Business

Walmart Beats Financial Forecast, Improves Full-Year Projections on Steady Consumer Demand

Related media - Recent news Walmart on Thursday raised its full-year guidance following a nearly 5% increase in quarterly revenue, fueled by increased activity at its brick-and-mortar stores and online platform, along with better-than-expected sales in non-food categories. The retail giant beat Wall Street forecasts in both revenue and profit, sending its stock price up 6% during morning trading. Walmart now expects full-year sales to rise 3.75% to 4.75%, with adjusted earnings per share between $2.35 and $2.43. The outlook change marks a change from previous projections, which called for sales growth of 3% to 4% and earnings per share…
Read More
Chipotle Reshuffles Leadership With Niccol Departing for Starbucks
15
Aug
Avatar photo
By Jean Thompson
Investments and Business

Chipotle Reshuffles Leadership With Niccol Departing for Starbucks

More news - Recent news Chipotle Mexican Grill is undergoing a leadership change: CEO Brian Niccol is stepping down to take over at Starbucks. The unexpected announcement sent shockwaves through the market, with Chipotle shares dropping nearly 10% on the news. Niccol’s departure marks the end of an era for Chipotle, one marked by significant growth and recovery from past challenges. Under his leadership, the company successfully navigated the foodborne illness crisis and capitalized on changing consumer preferences. Chipotle’s board of directors has named Chief Operating Officer Scott Boatwright as interim CEO, retaining Chief Financial Officer Jack Hartung to ensure…
Read More
MDMA Therapy Setback: Journal Retracts Study After FDA Rejects Drug
15
Aug
Avatar photo
By Jean Thompson
Health

MDMA Therapy Setback: Journal Retracts Study After FDA Rejects Drug

Related media - Recent news Three research papers exploring MDMA-assisted therapy for PTSD have been retracted by the journal Psychopharmacology. This follows the recent rejection of MDMA for this use by the Food and Drug Administration (FDA). The retracted studies, written by researchers affiliated with Lykos Therapeutics, the company behind the rejected treatment application, were found to involve unethical conduct at one of the research sites. Lykos, however, maintains that the retracted research was not part of their submission to the FDA. This development adds another layer of complexity to the ongoing debate over MDMA-assisted therapy. While some research suggests…
Read More